⌘K

Home/Insiders/Adawi Kamal

AK

SEC Insider//CIK 0001788393

Adawi Kamal

CIK 00017883931 companySAN DIEGO, CA

Transactions

13

Companies

1

Filings

11

CIK

0001788393

Recent Transactions

13 trades

Sale
EXAGEN INC.$XGN
Common Stock
2024-03-04$1.91/sh−3,487→ 243,749 total
Sale
EXAGEN INC.$XGN
Common Stock
2024-03-04$1.91/sh−9,297→ 247,236 total
Award
EXAGEN INC.$XGN
Common Stock
2024-02-20+75,000→ 256,533 total
Sale
EXAGEN INC.$XGN
Common Stock
2024-02-06$1.95/sh−6,738→ 181,533 total
Sale
EXAGEN INC.$XGN
Common Stock
2023-03-02$2.30/sh−3,667→ 188,271 total
Award
EXAGEN INC.$XGN
Common Stock
2023-02-27+100,000→ 191,938 total
Sale
EXAGEN INC.$XGN
Common Stock
2023-02-08$2.69/sh−5,821→ 91,938 total
Tax Payment
EXAGEN INC.$XGN
Common Stock
2022-03-01$7.12/sh−3,241→ 97,759 total
Award
EXAGEN INC.$XGN
Common Stock
2022-02-04+63,500→ 101,000 total
Award
EXAGEN INC.$XGN
Stock Option(right to buy)
2021-02-23+12,500→ 12,500 total
Award
EXAGEN INC.$XGN
Common Stock
2021-02-23+37,500→ 37,500 total
Award
EXAGEN INC.$XGN
Stock Option(right to buy)
2020-01-09+52,500→ 52,500 total
Award
EXAGEN INC.$XGN
Stock Option (right to buy)
2019-09-18+21,635→ 21,635 total

Companies

1

EXAGEN INC.
Chief Financial Officer
$XGN

Recent Filings

11

Address

C/O EXAGEN INC. 1261 LIBERTY WAY, SUITE C

SAN DIEGO, CA, 92081

View on SEC.gov